Elicio Therapeutics, Inc. (ELTX)
Total Valuation
ELTX has a market cap or net worth of $72.57 million. The enterprise value is $63.21 million.
Market Cap | 72.57M |
Enterprise Value | 63.21M |
Important Dates
The next estimated earnings date is Wednesday, May 15, 2024, before market open.
Earnings Date | May 15, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
ELTX has 10.22 million shares outstanding. The number of shares has increased by 2,538.13% in one year.
Shares Outstanding | 10.22M |
Shares Change (YoY) | +2,538.13% |
Shares Change (QoQ) | +170.12% |
Owned by Insiders (%) | 55.49% |
Owned by Institutions (%) | 6.43% |
Float | 3.64M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 5.46 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.74, with a Debt / Equity ratio of 0.54.
Current Ratio | 1.74 |
Quick Ratio | n/a |
Debt / Equity | 0.54 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -92.27 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -87.80% |
Return on Capital (ROIC) | -147.79% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.27M |
Employee Count | 23 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +45.02% in the last 52 weeks.
Beta (1Y) | n/a |
52-Week Price Change | +45.02% |
50-Day Moving Average | 4.74 |
200-Day Moving Average | 7.36 |
Relative Strength Index (RSI) | 78.36 |
Average Volume (30 Days) | 119,386 |
Short Selling Information
The latest short interest is 28,405, so 0.28% of the outstanding shares have been sold short.
Short Interest | 28,405 |
Short Previous Month | 23,536 |
Short % of Shares Out | 0.28% |
Short % of Float | 0.78% |
Short Ratio (days to cover) | 0.54 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -30.21M |
Pretax Income | -29.19M |
Net Income | -29.19M |
EBITDA | -27.76M |
EBIT | -28.88M |
Earnings Per Share (EPS) | -$7.31 |
Balance Sheet
The company has $16.51 million in cash and $7.15 million in debt, giving a net cash position of $9.36 million or $0.92 per share.
Cash & Cash Equivalents | 16.51M |
Total Debt | 7.15M |
Net Cash | 9.36M |
Net Cash Per Share | $0.92 |
Equity / Book Value | 13.29M |
Book Value Per Share | 1.30 |
Working Capital | 8.45M |
Cash Flow
In the last 12 months, operating cash flow was -$27.22 million and capital expenditures -$32,000, giving a free cash flow of -$27.26 million.
Operating Cash Flow | -27.22M |
Capital Expenditures | -32,000 |
Free Cash Flow | -27.26M |
FCF Per Share | -$3.25 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
ELTX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -2,538.13% |
Shareholder Yield | -2,538.13% |
Earnings Yield | -40.23% |
FCF Yield | -37.56% |
Analyst Forecast
The average price target for ELTX is $11.00, which is 44.74% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $11.00 |
Price Target Difference | 44.74% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | 60.58% |
EPS Growth Forecast (5Y) | -36.55% |
Stock Splits
The last stock split was on June 2, 2023. It was a reverse split with a ratio of 1:10.
Last Split Date | Jun 2, 2023 |
Split Type | Reverse |
Split Ratio | 1:10 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |